- Home
- QH vs RAPT Comparison
QH vs RAPT Comparison
Compare QH & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QH
- RAPT
- Stock Information
- Founded
- QH 2012
- RAPT 2015
- Country
- QH China
- RAPT United States
- Employees
- QH N/A
- RAPT N/A
- Industry
- QH Business Services
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- QH Consumer Discretionary
- RAPT Health Care
- Exchange
- QH Nasdaq
- RAPT Nasdaq
- Market Cap
- QH 115.7M
- RAPT 122.9M
- IPO Year
- QH 2020
- RAPT 2019
- Fundamental
- Price
- QH $0.12
- RAPT $9.81
- Analyst Decision
- QH
- RAPT Buy
- Analyst Count
- QH 0
- RAPT 5
- Target Price
- QH N/A
- RAPT $33.40
- AVG Volume (30 Days)
- QH 18.4M
- RAPT 93.6K
- Earning Date
- QH 08-27-2025
- RAPT 08-07-2025
- Dividend Yield
- QH N/A
- RAPT N/A
- EPS Growth
- QH N/A
- RAPT N/A
- EPS
- QH 0.01
- RAPT N/A
- Revenue
- QH $417,431,053.00
- RAPT N/A
- Revenue This Year
- QH N/A
- RAPT N/A
- Revenue Next Year
- QH N/A
- RAPT N/A
- P/E Ratio
- QH $13.26
- RAPT N/A
- Revenue Growth
- QH N/A
- RAPT N/A
- 52 Week Low
- QH $0.09
- RAPT $5.67
- 52 Week High
- QH $2.27
- RAPT $26.56
- Technical
- Relative Strength Index (RSI)
- QH 22.24
- RAPT 45.89
- Support Level
- QH $0.09
- RAPT $9.55
- Resistance Level
- QH $0.14
- RAPT $13.50
- Average True Range (ATR)
- QH 0.11
- RAPT 1.02
- MACD
- QH -0.08
- RAPT -0.34
- Stochastic Oscillator
- QH 1.62
- RAPT 5.81
About QH Quhuo Limited American Depository Shares
Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.